Zimmer Biomet Holdings (ZBH) Return on Capital Employed (2009 - 2026)
Zimmer Biomet Holdings' (ZBH) quarterly Return on Capital Employed came in at 5.88% in Q1 2026, down 8449.0% year-on-year from 0.07% in Q1 2025, and down 41.06% quarter-over-quarter from 9.98% in Q4 2025.
Zimmer Biomet Holdings (ZBH) Return on Capital Employed (2009 - 2026) Analysis & Trends
Zimmer Biomet Holdings' Return on Capital Employed history runs 18 years deep, the most recent figure standing at 5.88% for Q1 2026.
- On a quarterly basis, Return on Capital Employed fell 8449.0% year-over-year to 5.88% in Q1 2026; TTM through Mar 2026 was 5.88%, a 8449.0% decrease from a year earlier, with the FY2025 full-year figure at 10.15%, down 251.0% from the prior year.
- Return on Capital Employed slipped to 5.88% in Q1 2026 per ZBH's latest filing, from 9.98% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 103.17% in Q2 2025 and bottomed at 4.03% in Q1 2022.
- The 5-year median for Return on Capital Employed is 6.91% (2022), against an average of 21.55%.
- Across the five-year window, Return on Capital Employed soared 9625 bps in 2025 and tumbled 8449 bps in 2026, its largest moves.
- Year by year, Return on Capital Employed stood at 6.91% in 2022, then decreased by 0 bps to 6.91% in 2023, then soared by 81 bps to 12.52% in 2024, then declined by 20 bps to 9.98% in 2025, then plunged by 41 bps to 5.88% in 2026.
- Per Business Quant, the three latest ZBH Return on Capital Employed figures stand at 5.88% (Q1 2026), 9.98% (Q4 2025), and 79.76% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 11.13% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 24.24% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.38% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 9.30% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Zimmer Biomet Holdings | 17.48 Bn | 17.07 Bn | 1.51 Bn | 5.88% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.88% |
| Dec 31, 2025 | 9.98% |
| Sep 30, 2025 | 79.76% |
| Jun 30, 2025 | 103.17% |
| Mar 31, 2025 | 90.37% |
| Dec 31, 2024 | 12.52% |
| Sep 30, 2024 | 6.93% |
| Jun 30, 2024 | 6.92% |
| Mar 31, 2024 | 6.51% |
| Dec 31, 2023 | 6.91% |
| Sep 30, 2023 | 4.67% |
| Jun 30, 2023 | 4.59% |
| Mar 31, 2023 | 8.21% |
| Dec 31, 2022 | 6.91% |
| Sep 30, 2022 | 4.49% |
| Jun 30, 2022 | 4.49% |
| Mar 31, 2022 | 4.03% |
| Dec 31, 2021 | 3.01% |
| Sep 30, 2021 | 4.19% |
| Jun 30, 2021 | 4.45% |